- Home
- MAZE vs CLPT Comparison
MAZE vs CLPT Comparison
Compare MAZE & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAZE
- CLPT
- Stock Information
- Founded
- MAZE 2018
- CLPT 1998
- Country
- MAZE United States
- CLPT United States
- Employees
- MAZE N/A
- CLPT N/A
- Industry
- MAZE
- CLPT Medical/Dental Instruments
- Sector
- MAZE
- CLPT Health Care
- Exchange
- MAZE NYSE
- CLPT Nasdaq
- Market Cap
- MAZE 367.0M
- CLPT 338.0M
- IPO Year
- MAZE 2025
- CLPT N/A
- Fundamental
- Price
- MAZE $16.93
- CLPT $11.04
- Analyst Decision
- MAZE Strong Buy
- CLPT Strong Buy
- Analyst Count
- MAZE 4
- CLPT 3
- Target Price
- MAZE $23.50
- CLPT $27.67
- AVG Volume (30 Days)
- MAZE 129.8K
- CLPT 571.6K
- Earning Date
- MAZE 08-14-2025
- CLPT 08-06-2025
- Dividend Yield
- MAZE N/A
- CLPT N/A
- EPS Growth
- MAZE N/A
- CLPT N/A
- EPS
- MAZE 0.34
- CLPT N/A
- Revenue
- MAZE $167,500,000.00
- CLPT $32,235,999.00
- Revenue This Year
- MAZE N/A
- CLPT $23.97
- Revenue Next Year
- MAZE N/A
- CLPT $27.52
- P/E Ratio
- MAZE $53.00
- CLPT N/A
- Revenue Growth
- MAZE N/A
- CLPT 23.22
- 52 Week Low
- MAZE $6.71
- CLPT $6.25
- 52 Week High
- MAZE $18.50
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- MAZE N/A
- CLPT 44.77
- Support Level
- MAZE N/A
- CLPT $10.81
- Resistance Level
- MAZE N/A
- CLPT $11.61
- Average True Range (ATR)
- MAZE 0.00
- CLPT 0.60
- MACD
- MAZE 0.00
- CLPT -0.00
- Stochastic Oscillator
- MAZE 0.00
- CLPT 36.08
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.